Contains viable, selected strains of human adenovirus type 4 and human adenovirus type 7 prepared in human-diploid fibroblast cell cultures (strain wi-38); virus strains have not been attenuated; cells are grown and the virus growth maintained in dulbecco's modified eagle's medium, fetal bovine serum, and sodium bicarbonate; approved for use in military populations 17-50 years of age; indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7; carton consists of one bottle of 100 tablets adenovirus type 4 (ndc 51285-174-02) and one bottle of 100 tablets adenovirus type 7 (ndc 51285-175-02); store refrigerated between 2-8 degrees c (35-46 degrees f); do not freeze; keep bottle tightly closed and protect from moisture; do not remove desiccant canister from bottle; prescription only; for oral administration; dosage: one tablet of adenovirus type 4 component and one tablet of adenovirus type 7 component
NSN 6110-01-547-6274
NSN 5920-01-442-7685
NSN 5999-01-419-9504
NSN 5960-00-682-3598
NSN 5996-00-753-1599
NSN 5950-01-285-3404
NSN 6240-01-546-0819
NSN 6130-01-026-0603
NSN 5895-00-995-9430
NSN 6320-00-646-3311
NSN 5905-00-361-9539
NSN 5930-01-420-5922